Related references
Note: Only part of the references are listed.PD-1 Blockade Aggravates Epstein-Barr Virus+ Post-Transplant Lymphoproliferative Disorder in Humanized Mice Resulting in Central Nervous System Involvement and CD4+ T Cell Dysregulations
Valery Volk et al.
FRONTIERS IN ONCOLOGY (2021)
Primary immunodeficiencies reveal the molecular requirements for effective host defense against EBV infection
Stuart G. Tangye et al.
BLOOD (2020)
Extended clinical and immunological phenotype and transplant outcome in CD27 and CD70 deficiency
Sujal Ghosh et al.
BLOOD (2020)
EBV renders B cells susceptible to HIV-1 in humanized mice
Donal McHugh et al.
LIFE SCIENCE ALLIANCE (2020)
Immunodeficiency and EBV-induced lymphoproliferation caused by 4-1BB deficiency
Mohammed F. Alosaimi et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2019)
Infection and immune control of human oncogenic γ-herpesviruses in humanized mice
Donal Mchugh et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2019)
CD8+ T cells retain protective functions despite sustained inhibitory receptor expression during Epstein-Barr virus infection in vivo
Bithi Chatterjee et al.
PLOS PATHOGENS (2019)
A case report of clonal EBV-like memory CD4+ T cell activation in fatal checkpoint inhibitor-induced encephalitis
Douglas B. Johnson et al.
NATURE MEDICINE (2019)
Epstein-Barr virus reprograms human B lymphocytes immediately in the prelatent phase of infection
Paulina Mrozek-Gorska et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Signaling pathways involved in the T-cell-mediated immunity against Epstein-Barr virus: Lessons from genetic diseases
Sylvain Latour et al.
IMMUNOLOGICAL REVIEWS (2019)
Latency and lytic replication in Epstein-Barr virus-associated oncogenesis
Christian Muenz
NATURE REVIEWS MICROBIOLOGY (2019)
First Days in the Life of Naive Human B Lymphocytes Infected with Epstein-Barr Virus
Dagmar Pich et al.
MBIO (2019)
The Global Landscape of EBV-Associated Tumors
Claire Shannon-Lowe et al.
FRONTIERS IN ONCOLOGY (2019)
Immunodeficiencies that predispose to pathologies by human oncogenic γ-herpesviruses
Blossom Damania et al.
FEMS MICROBIOLOGY REVIEWS (2019)
Phenotype, penetrance, and treatment of 133 cytotoxic T-lymphocyte antigen 4-insufficient subjects
Charlotte Schwab et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2018)
Inherited Immunodeficiencies With High Predisposition to Epstein-Barr Virus-Driven Lymphoproliferative Diseases
Sylvain Latour et al.
FRONTIERS IN IMMUNOLOGY (2018)
The importance of CD39, CD43, CD81, and CD95 expression for differentiating B cell lymphoma by flow cytometry
Chandra Chiappin Cardoso et al.
CYTOMETRY PART B-CLINICAL CYTOMETRY (2018)
Loss of RASGRP1 in humans impairs T-cell expansion leading to Epstein-Barr virus susceptibility
Sarah Winter et al.
EMBO MOLECULAR MEDICINE (2018)
Inherited CD70 deficiency in humans reveals a critical role for the CD70-CD27 pathway in immunity to Epstein-Barr virus infection
Kazushi Izawa et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
Combined immunodeficiency and Epstein-Barr virus-induced B cell malignancy in humans with inherited CD70 deficiency
Hassan Abolhassani et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
Humanized mouse models for Epstein Barr virus infection
Christian Muenz
CURRENT OPINION IN VIROLOGY (2017)
Does persistent HIV replication explain continued lymphoma incidence in the era of effective antiretroviral therapy?
Jennifer Totonchy et al.
CURRENT OPINION IN VIROLOGY (2016)
Early T Cell Recognition of B Cells following Epstein-Barr Virus Infection: Identifying Potential Targets for Prophylactic Vaccination
Jill M. Brooks et al.
PLOS PATHOGENS (2016)
The immunology of Epstein-Barr Virus Induced Disease
Graham S. Taylor et al.
ANNUAL REVIEW OF IMMUNOLOGY VOL 33 (2015)
Novel mutations in TNFRSF7/CD27: Clinical, immunologic, and genetic characterization of human CD27 deficiency
Omar K. Alkhairy et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2015)
Role of the 2B4 Receptor in CD8+ T-Cell-Dependent Immune Control of Epstein-Barr Virus Infection in Mice With Reconstituted Human Immune System Components
Obinna Chijioke et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
XLP: Clinical Features and Molecular Etiology due to Mutations in SH2D1A Encoding SAP
Stuart G. Tangye
JOURNAL OF CLINICAL IMMUNOLOGY (2014)
Adoptive Transfer of EBV Specific CD8+ T Cell Clones Can Transiently Control EBV Infection in Humanized Mice
Olga Antsiferova et al.
PLOS PATHOGENS (2014)
The costimulatory molecule CD70 is regulated by distinct molecular mechanisms and is associated with overall survival in diffuse large B-cell lymphoma
P. Bertrand et al.
GENES CHROMOSOMES & CANCER (2013)
Combined immunodeficiency with life-threatening EBV-associated lymphoproliferative disorder in patients lacking functional CD27
Elisabeth Salzer et al.
HAEMATOLOGICA (2013)
Mg2+ Regulates Cytotoxic Functions of NK and CD8 T Cells in Chronic EBV Infection Through NKG2D
Benjamin Chaigne-Delalande et al.
SCIENCE (2013)
Human Natural Killer Cells Prevent Infectious Mononucleosis Features by Targeting Lytic Epstein-Barr Virus Infection
Obinna Chijioke et al.
CELL REPORTS (2013)
CD27 deficiency is associated with combined immunodeficiency and persistent symptomatic EBV viremia
Joris M. van Montfrans et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2012)
Progenitor and Terminal Subsets of CD8+ T Cells Cooperate to Contain Chronic Viral Infection
Michael A. Paley et al.
SCIENCE (2012)
SLAM Family Receptors and SAP Adaptors in Immunity
Jennifer L. Cannons et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 29 (2011)
Epstein-Barr Virus: An Important Vaccine Target for Cancer Prevention
Jeffrey I. Cohen et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Impaired Epstein-Barr virus-specific CD8+ T-cell function in X-linked lymphoproliferative disease is restricted to SLAM family-positive B-cell targets
Andrew D. Hislop et al.
BLOOD (2010)
A diacylglycerol-protein kinase C-RasGRP1 pathway directs Ras activation upon antigen receptor stimulation of T cells
JP Roose et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections
V Appay et al.
NATURE MEDICINE (2002)
Tonsillar memory B cells, latently infected with Epstein-Barr virus, express the restricted pattern of latent genes previously found only in Epstein-Barr virus-associated tumors
GJ Babcock et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
X-linked lymphoproliferative disease: 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill Epstein-Barr virus-infected cells
S Parolini et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Share Paper
